Brenda Libby Coleman

Array ( [id] => 4132258 [patent_doc_number] => 06034098 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Inhibitors of microsomal triglyceride transfer protein and method' [patent_app_type] => 1 [patent_app_number] => 8/898304 [patent_app_country] => US [patent_app_date] => 1997-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61924 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 309 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034098.pdf [firstpage_image] =>[orig_patent_app_number] => 898304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4101617 [patent_doc_number] => 06066650 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Inhibitors of microsomal triglyceride transfer protein and method' [patent_app_type] => 1 [patent_app_number] => 8/898303 [patent_app_country] => US [patent_app_date] => 1997-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60732 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 231 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066650.pdf [firstpage_image] =>[orig_patent_app_number] => 898303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995991 [patent_doc_number] => 05985869 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Benzoheterocyclic compounds' [patent_app_type] => 1 [patent_app_number] => 8/893925 [patent_app_country] => US [patent_app_date] => 1997-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 99328 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 2240 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985869.pdf [firstpage_image] =>[orig_patent_app_number] => 893925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3761530 [patent_doc_number] => 05843944 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Tricyclic diazepine vasopressin antagonists and oxytocin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/893636 [patent_app_country] => US [patent_app_date] => 1997-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60797 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 779 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843944.pdf [firstpage_image] =>[orig_patent_app_number] => 893636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3742080 [patent_doc_number] => 05786353 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-28 [patent_title] => 'Tricyclic benzazepine vasopressin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/893497 [patent_app_country] => US [patent_app_date] => 1997-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51127 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 927 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/786/05786353.pdf [firstpage_image] =>[orig_patent_app_number] => 893497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3761655 [patent_doc_number] => 05843952 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Tricyclic benzazepine vasopressin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/889858 [patent_app_country] => US [patent_app_date] => 1997-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52321 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 383 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843952.pdf [firstpage_image] =>[orig_patent_app_number] => 889858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808008 [patent_doc_number] => 05854237 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Tricyclic diazepine vasopressin antagonists and oxytocin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/877314 [patent_app_country] => US [patent_app_date] => 1997-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60697 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 778 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854237.pdf [firstpage_image] =>[orig_patent_app_number] => 877314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4008650 [patent_doc_number] => 05889001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Tricyclic diazepine vasopressin antagonists and oxytocin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/874835 [patent_app_country] => US [patent_app_date] => 1997-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57509 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 667 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889001.pdf [firstpage_image] =>[orig_patent_app_number] => 874835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4074518 [patent_doc_number] => 05965553 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Squalene synthetase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/874089 [patent_app_country] => US [patent_app_date] => 1997-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22689 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 1119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965553.pdf [firstpage_image] =>[orig_patent_app_number] => 874089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4010093 [patent_doc_number] => 05962451 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Benzodiazepin derivatives useful as CCK-receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 8/867422 [patent_app_country] => US [patent_app_date] => 1997-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30222 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 319 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962451.pdf [firstpage_image] =>[orig_patent_app_number] => 867422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4239513 [patent_doc_number] => 06090825 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Oxazole derivatives as antagonists of alpha 1C andrenergic receptors' [patent_app_type] => 1 [patent_app_number] => 8/849016 [patent_app_country] => US [patent_app_date] => 1997-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27627 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090825.pdf [firstpage_image] =>[orig_patent_app_number] => 849016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360091 [patent_doc_number] => 06191165 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Pharmaceutical for treatment of neurological and neuropsychiatric disorders' [patent_app_type] => 1 [patent_app_number] => 8/866007 [patent_app_country] => US [patent_app_date] => 1997-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22681 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1532 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/191/06191165.pdf [firstpage_image] =>[orig_patent_app_number] => 866007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3938298 [patent_doc_number] => 05972975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Substituted 2-aminopyridines as inhibitors of nitric oxide synthase' [patent_app_type] => 1 [patent_app_number] => 8/836953 [patent_app_country] => US [patent_app_date] => 1997-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26757 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 446 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972975.pdf [firstpage_image] =>[orig_patent_app_number] => 836953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272077 [patent_doc_number] => 06245773 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => '5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines' [patent_app_type] => 1 [patent_app_number] => 8/858017 [patent_app_country] => US [patent_app_date] => 1997-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 72293 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 780 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245773.pdf [firstpage_image] =>[orig_patent_app_number] => 858017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645445 [patent_doc_number] => 06472525 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Hexaazaisowurtzitane derivative and method for producing the same' [patent_app_type] => B1 [patent_app_number] => 08/737094 [patent_app_country] => US [patent_app_date] => 1997-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17135 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472525.pdf [firstpage_image] =>[orig_patent_app_number] => 08737094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4009205 [patent_doc_number] => 05889032 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them' [patent_app_type] => 1 [patent_app_number] => 8/851448 [patent_app_country] => US [patent_app_date] => 1997-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23656 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889032.pdf [firstpage_image] =>[orig_patent_app_number] => 851448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4009862 [patent_doc_number] => 05962437 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Lipid analogs for treating viral infections' [patent_app_type] => 1 [patent_app_number] => 8/793470 [patent_app_country] => US [patent_app_date] => 1997-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8441 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962437.pdf [firstpage_image] =>[orig_patent_app_number] => 793470 [rel_patent_id] =>[rel_patent_doc_number] =>)